Anti‑inflammatory and anti‑catabolic effect of non‑animal stabilized hyaluronic acid and mesenchymal stem cell‑conditioned medium in an osteoarthritis coculture model

Simental‑Mendía,Mario; Lozano‑Sepúlveda,Sonia  Amelia; Pérez‑Silos,Vanessa; Fuentes‑Mera,Lizeth; Martínez‑Rodríguez,Herminia  Guadalupe; Acosta‑Olivo,Carlos   Alberto; Peña‑Martínez,Víctor  Manuel; Vilchez‑Cavazos,Félix

doi:10.3892/mmr.2020.11004

Anti‑inflammatory and anti‑catabolic effect of non‑animal stabilized hyaluronic acid and mesenchymal stem cell‑conditioned medium in an osteoarthritis coculture model

Authors:
- Mario Simental‑Mendía
- Sonia Amelia Lozano‑Sepúlveda
- Vanessa Pérez‑Silos
- Lizeth Fuentes‑Mera
- Herminia Guadalupe Martínez‑Rodríguez
- Carlos Alberto Acosta‑Olivo
- Víctor Manuel Peña‑Martínez
- Félix Vilchez‑Cavazos
View Affiliations

Affiliations: Orthopedics and Traumatology Service, School of Medicine and University Hospital ‘Dr. José Eleuterio González’, Universidad Autonoma de Nuevo León, Monterrey, Nuevo León 64460, México, Department of Biochemistry and Molecular Medicine, School of Medicine, Universidad Autonoma de Nuevo León, Monterrey, Nuevo León 64460, México
Published online on: February 26, 2020 https://doi.org/10.3892/mmr.2020.11004
Pages: 2243-2250

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous clinical studies have reported the clinical effectiveness of non‑animal stabilized hyaluronic acid (NASHA) and adipose‑derived mesenchymal stromal/stem cells (MSC) in the treatment of knee osteoarthritis (OA). Unlike MSC secreted mediators, in vitro anti‑inflammatory effects of NASHA have not been evaluated. We aimed to evaluate and compare the anti‑inflammatory effect of NASHA and MSC conditioned medium (stem cell‑conditioned medium; SC‑CM), in an explant‑based coculture model of OA. Cartilage and synovial membrane from seven patients undergoing total knee arthroplasty were used to create a coculture system. Recombinant IL‑1β was added to the cocultures to induce inflammation. Four experimental groups were generated: i) Basal; ii) IL‑1β; iii) NASHA (NASHA + IL‑1β); and iv) SC‑CM (SC‑CM + IL‑1β). Glycosaminoglycans (GAG) released in the culture medium and of nitric oxide (NO) production were quantified. Gene expression in cartilage and synovium of IL‑1β, matrix metallopeptidase 13 (MMP13), ADAM metallopeptidase with thrombospondin type 1 motif 5 (ADAMTS5) and tissue inhibitor of metalloproteinases 1 (TIMP1) was measured by reverse transcription‑quantitative PCR. Media GAG concentration was decreased in cocultures with NASHA and SC‑CM (48 h, P<0.05; 72 h, P<0.01) compared with IL‑1β. Production of NO was significantly lower only in SC‑CM after 72 h (P<0.01). In cartilage, SC‑CM inhibited the expression of IL‑1β, MMP13 and ADAMTS5, while NASHA had this effect only in MMP13 and ADAMTS5. In synovium, SC‑CM decreased the expression level of MMP13 and ADAMTS5, while NASHA only decreased ADAMTS5 expression. Both NASHA and SC‑CM increased TIMP1 expression in cartilage and synovium. Treatments with NASHA and SC‑CM were shown to be a therapeutic option that may help counteract the catabolism produced by the inflammatory state in knee OA. The anti‑inflammatory mediators produced by MSC promote a lower expression of inflammatory targets in our study model.

View Figures

View References

1	Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, et al: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II. Arthritis Rheum. 58:26–35. 2008. View Article : Google Scholar : PubMed/NCBI
2	Shen J, Abu-Amer Y, O'Keefe RJ and McAlinden A: Inflammation and epigenetic regulation in osteoarthritis. Connect Tissue Res. 58:49–63. 2017. View Article : Google Scholar : PubMed/NCBI
3	Jørgensen AEM, Kjær M and Heinemeier KM: The effect of aging and mechanical loading on the metabolism of articular cartilage. J Rheumatol. 44:410–417. 2017. View Article : Google Scholar : PubMed/NCBI
4	Tetlow LC, Adlam DJ and Woolley DE: Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: Associations with degenerative changes. Arthritis Rheum. 44:585–594. 2001. View Article : Google Scholar : PubMed/NCBI
5	Goldring MB, Otero M, Tsuchimochi K, Ijiri K and Li Y: Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann Rheum Dis. 67 (Suppl 3):iii75–iii82. 2008. View Article : Google Scholar : PubMed/NCBI
6	Li MH, Xiao R, Li JB and Zhu Q: Regenerative approaches for cartilage repair in the treatment of osteoarthritis. Osteoarthritis Cartilage. 25:1577–1587. 2017. View Article : Google Scholar : PubMed/NCBI
7	Jones IA, Togashi R, Wilson ML, Heckmann N and Vangsness CT Jr: Intra-articular treatment options for knee osteoarthritis. Nat Rev Rheumatol. 15:77–90. 2019. View Article : Google Scholar : PubMed/NCBI
8	Evans CH, Kraus VB and Setton LA: Progress in intra-articular therapy. Nat Rev Rheumatol. 10:11–22. 2014. View Article : Google Scholar : PubMed/NCBI
9	Agerup B, Berg P and Akermark C: Non-animal stabilized hyaluronic acid: A new formulation for the treatment of osteoarthritis. BioDrugs. 19:23–30. 2005. View Article : Google Scholar : PubMed/NCBI
10	Leighton R, Fitzpatrick J, Smith H, Crandall D, Flannery CR and Conrozier T: Systematic clinical evidence review of NASHA (Durolane hyaluronic acid) for the treatment of knee osteoarthritis. Open access Rheumatol. 10:43–54. 2018. View Article : Google Scholar : PubMed/NCBI
11	Gupta PK, Chullikana A, Rengasamy M, Shetty N, Pandey V, Agarwal V, Wagh SY, Vellotare PK, Damodaran D, Viswanathan P, et al: Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel^®): Preclinical and clinical trial in osteoarthritis of the knee joint. Arthritis Res Ther. 18:3012016. View Article : Google Scholar : PubMed/NCBI
12	Pers YM, Rackwitz L, Ferreira R, Pullig O, Delfour C, Barry F, Sensebe L, Casteilla L, Fleury S, Bourin P, et al: Adipose mesenchymal stromal Cell-based therapy for severe osteoarthritis of the knee: A phase I dose-escalation trial. Stem Cells Transl Med. 5:847–856. 2016. View Article : Google Scholar : PubMed/NCBI
13	Timmers L, Lim SK, Hoefer IE, Arslan F, Lai RC, van Oorschot AA, Goumans MJ, Strijder C, Sze SK, Choo A, et al: Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res. 6:206–214. 2011. View Article : Google Scholar : PubMed/NCBI
14	Le Blanc K and Mougiakakos D: Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 12:383–396. 2012. View Article : Google Scholar : PubMed/NCBI
15	Caplan AI: Mesenchymal stem cells: Time to change the Name! Stem Cells Transl Med. 6:1445–1451. 2017. View Article : Google Scholar : PubMed/NCBI
16	van Buul GM, Villafuertes E, Bos PK, Waarsing JH, Kops N, Narcisi R, Weinans H, Verhaar JA, Bernsen MR and van Osch GJ: Mesenchymal stem cells secrete factors that inhibit inflammatory processes in short-term osteoarthritic synovium and cartilage explant culture. Osteoarthritis Cartilage. 20:1186–1196. 2012. View Article : Google Scholar : PubMed/NCBI
17	Platas J, Guillén MI, del Caz MD, Gomar F, Mirabet V and Alcaraz MJ: Conditioned media from adipose-tissue-derived mesenchymal stem cells downregulate degradative mediators induced by interleukin-1β in osteoarthritic chondrocytes. Mediators Inflamm. 2013:3570142013. View Article : Google Scholar : PubMed/NCBI
18	Crop MJ, Baan CC, Korevaar SS, Ijzermans JN, Pescatori M, Stubbs AP, van Ijcken WF, Dahlke MH, Eggenhofer E, Weimar W and Hoogduijn MJ: Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells. Clin Exp Immunol. 162:474–486. 2010. View Article : Google Scholar : PubMed/NCBI
19	Khatab S, van Osch GJ, Kops N, Bastiaansen-Jenniskens YM, Bos PK, Verhaar JA, Bernsen MR and van Buul GM: Mesenchymal stem cell secretome reduces pain and prevents cartilage damage in a murine osteoarthritis model. Eur Cell Mater. 36:218–230. 2018. View Article : Google Scholar : PubMed/NCBI
20	Hernandez-Hurtado AA, Borrego-Soto G, Marino-Martinez IA, Lara-Arias J, Romero-Diaz VJ, Abrego-Guerra A, Vilchez-Cavazos JF, Elizondo-Riojas G, Martinez-Rodriguez HG, Espinoza-Juarez MA, et al: Implant composed of demineralized bone and mesenchymal stem cells genetically modified with AdBMP2/AdBMP7 for the regeneration of bone fractures in ovis aries. Stem Cells Int. 2016:74038902016. View Article : Google Scholar : PubMed/NCBI
21	Ciuffreda MC, Malpasso G, Musarò P, Turco V and Gnecchi M: Protocols for in vitro differentiation of human mesenchymal stem cells into osteogenic, chondrogenic and adipogenic lineages. Methods Mol Biol. 1416:149–158. 2016. View Article : Google Scholar : PubMed/NCBI
22	Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e452001. View Article : Google Scholar : PubMed/NCBI
23	Sellam J and Berenbaum F: The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 6:625–635. 2010. View Article : Google Scholar : PubMed/NCBI
24	Osterman C, McCarthy MB, Cote MP, Beitzel K, Bradley J, Polkowski G and Mazzocca AD: Platelet-Rich plasma increases Anti-inflammatory markers in a human coculture model for osteoarthritis. Am J Sports Med. 43:1474–1484. 2015. View Article : Google Scholar : PubMed/NCBI
25	Johnson CI, Argyle DJ and Clements DN: In vitro models for the study of osteoarthritis. Vet J. 209:40–49. 2016. View Article : Google Scholar : PubMed/NCBI
26	Choi CH, Kim TH, Sung YK, Choi CB, Na YI, Yoo H and Jun JB: SKI306X inhibition of glycosaminoglycan degradation in human cartilage involves down-regulation of cytokine-induced catabolic genes. Korean J Intern Med. 29:647–655. 2014. View Article : Google Scholar : PubMed/NCBI
27	Behrendt P, Preusse-Prange A, Klüter T, Haake M, Rolauffs B, Grodzinsky AJ, Lippross S and Kurz B: IL-10 reduces apoptosis and extracellular matrix degradation after injurious compression of mature articular cartilage. Osteoarthritis Cartilage. 24:1981–1988. 2016. View Article : Google Scholar : PubMed/NCBI
28	Gierman LM, van El B, van der Ham F, Koudijs A, Stoop R, Verheijen JH, Kloppenburg M, van Osch GJ, Stojanovic-Susulic V, Huizinga TW and Zuurmond AM: Profiling the secretion of soluble mediators by end stage osteoarthritis synovial tissue explants reveals a reduced responsiveness to an inflammatory trigger. PLoS One. 8:e626342013. View Article : Google Scholar : PubMed/NCBI
29	Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP and Fahmi H: Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 7:33–42. 2011. View Article : Google Scholar : PubMed/NCBI
30	Abramson SB: Osteoarthritis and nitric oxide. Osteoarthritis Cartilage. 16 (Suppl 2):S15–S20. 2008. View Article : Google Scholar : PubMed/NCBI
31	Haltmayer E, Ribitsch I, Gabner S, Rosser J, Gueltekin S, Peham J, Giese U, Dolezal M, Egerbacher M and Jenner F: Co-culture of osteochondral explants and synovial membrane as in vitro model for osteoarthritis. PLoS One. 14:e02147092019. View Article : Google Scholar : PubMed/NCBI
32	Koshy PJ, Lundy CJ, Rowan AD, Porter S, Edwards DR, Hogan A, Clark IM and Cawston TE: The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: A time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum. 46:961–967. 2002. View Article : Google Scholar : PubMed/NCBI
33	Pratta MA, Yao W, Decicco C, Tortorella MD, Liu RQ, Copeland RA, Magolda R, Newton RC, Trzaskos JM and Arner EC: Aggrecan protects cartilage collagen from proteolytic cleavage. J Biol Chem. 278:45539–45545. 2003. View Article : Google Scholar : PubMed/NCBI
34	Simental-Mendía M, Vilchez-Cavazos F, García-Garza R, Lara-Arias J, Montes-de-Oca-Luna R, Said-Fernández S and Martínez-Rodríguez HG: The matrix synthesis and anti-inflammatory effect of autologous leukocyte-poor platelet rich plasma in human cartilage explants. Histol Histopathol. 33:609–618. 2018.PubMed/NCBI
35	Brew K and Nagase H: The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity. Biochim Biophys Acta. 1803:55–71. 2010. View Article : Google Scholar : PubMed/NCBI
36	Leighton R, Akermark C, Therrien R, Richardson JB, Andersson M, Todman MG and Arden NK; DUROLANE Study Group, : NASHA hyaluronic acid vs methylprednisolone for knee osteoarthritis: A prospective, multi-centre, randomized, non-inferiority trial. Osteoarthritis Cartilage. 22:17–25. 2014. View Article : Google Scholar : PubMed/NCBI
37	Altman RD, Akermark C, Beaulieu AD and Schnitzer T; Durolane International Study Group, : Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage. 12:642–649. 2004. View Article : Google Scholar : PubMed/NCBI
38	Estades-Rubio FJ, Reyes-Martín A, Morales-Marcos V, García-Piriz M, García-Vera JJ, Perán M, Marchal JA and Montañez-Heredia E: Knee viscosupplementation: Cost-effectiveness analysis between stabilized hyaluronic acid in a single injection versus five injections of standard hyaluronic acid. Int J Mol Sci. 18(pii): E6582017. View Article : Google Scholar : PubMed/NCBI
39	Singer NG and Caplan AI: Mesenchymal stem cells: Mechanisms of inflammation. Annu Rev Pathol. 6:457–478. 2011. View Article : Google Scholar : PubMed/NCBI
40	Altman R, Bedi A, Manjoo A, Niazi F, Shaw P and Mease P: Anti-inflammatory effects of Intra-articular hyaluronic acid: A systematic review. Cartilage. 10:43–52. 2019. View Article : Google Scholar : PubMed/NCBI